Clinical Trials Browser

Hematologic Neoplasms × Bortezomib × 30 days × Clear all

NCT03850366 2026-02-24

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms